Aadi Bioscience

Aadi Bioscience is a small oncology-focused biotech name, and that focus is the first thing worth noticing. By our assessment, it is strongest when you think about targeted cancer medicines and the hard work of pushing a narrow scientific idea into treatment. That kind of company can be valuable precisely because it is not broad: it concentrates on one medical problem instead of trying to be everything at once. The downside is the usual biotech one, but it is real here — narrow pipelines can be fragile, and the whole story depends on whether a specific drug program succeeds. In practice this kind of firm feels very different from a large pharma brand: fewer products, more technical risk, and a lot of waiting around the science. Aadi Bioscience is for people who understand that biotechnology is often a long wager, not a finished shelf of medicines.